During the past decade, Duly Health and Care Joliet conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 26 clinical trials were completed, i.e. on average, 113% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duly Health and Care Joliet" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "GOG Foundation" with 2 trials sponsored and "G1 Therapeutics, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duly Health and Care Joliet" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Duly Health and Care Joliet" are "Recurrent Breast Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Invasive Breast Carcinoma" (3 trials) and "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials). Many other conditions were trialed in "Duly Health and Care Joliet" in a lesser frequency.

Most popular intervention types in "Duly Health and Care Joliet" are "Drug" (47 trials), "Other" (41 trials), "Biological" (35 trials), "Procedure" (12 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (17 trials), "Paclitaxel" (12 trials), "Questionnaire Administration" (10 trials) and "Bevacizumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Duly Health and Care Joliet" are 45 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Duly Health and Care Joliet". undefined are not yet recruiting, 12 are recruiting, 36 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Duly Health and Care Joliet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duly Health and Care Joliet, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".